Xiebai relies on wild resources, and the market outlook is expected to rise slowly!

Xiebai is a small variety, mainly supplied to the market from wild resources
.
In the fall of 2021, new production will be reduced, causing the market to rise.
In the spring of 2022, new production will continue to be reduced.
How will the market work? In this issue, the big data platform of the pharmaceutical industry of Tiandi Yuntu makes an analysis of the market of this variety based on the production and sales data
.
1.
Movements of Xiebai market and production area Bozhou market: Xiebai production is new and in-depth, and there is news from the production area that the output of new products this year is small, so the market performance is strong after the new production
.
The supply of goods in the market is generally sold, the number of new goods on the market is currently relatively small, and the market is running smoothly.
The price of unified goods is 37 yuan (kg price, the same below)
.
Anguo market: Xiebai production area is in the process of new production, the market volume has been small in recent days, and the market has remained stable for the time being
.
At present, the market price is 36 yuan for general goods, and the price of medium-sized goods is about 39 yuan.
The purchase and sale of small batches are normal
.
Yulin Market: In 2021, the supply and output of Xiebai in autumn will be low, and many holders of goods will be reluctant to sell, and the market price will rise steadily in the early stage
.
Recently, the production area has continued to produce new products, and the market has declined slightly.
The market price of goods is around 36 yuan.
The market outlook will continue to pay attention to the situation of the supply of goods entering the market
.
According to the businessman of Shaanxi Xiebai, the local new products entered the market, the market has declined, and the overall movement is not fast
.
The price of Xiebai from the origin is 30 yuan, and the price of high-quality goods is 35 yuan.
It is understood that the output of new products this year is not large, and the price is expected to change in the future
.
2.
Harvesting costs increase and prices rise Figure: 2017-2022 Xiebai market price chart Before and after the new production in 2010, the Xiebai market rose to a historically high price of around 50 yuan
.
Under the stimulation of high prices, the supply of goods increased greatly.
As a result, after the end of new production in 2011, the price fell to a trough below 20 yuan
.
Beginning in 2016, with the weak inventory of Xiebai and the low price, the harvest of medicinal farmers was not active, and the new supply and production volume were not large, and the price rebounded.
The overall price in 2016 was around 33 yuan.

.
In the new production period in 2017, affected by the weather, the new production of glutinous rice in the production area was relatively small, which stimulated buyers to actively purchase goods and drove the price to rise
.
After the production of new products in 2018, the market of this variety declined, and the market rebounded in 2019, but with little strength
.
Affected by the epidemic in 2020, there were many harvesters, the market fell, and there was a slight rebound in autumn; the new market in 2021 was the same as the same period in 2020
.
3.
The output is relatively stable, and the contradiction between supply and demand is not obvious.
Xiebai is the dry bulb of the perennial herb of Liliaceae, garlic
.
After excavation in summer and autumn every year, wash clean, remove seedlings, steam or scald in boiling water, and dry in the sun
.
This variety is a dual-use variety for medicine and food, and it is distributed all over the country.
Shandong, Henan, Shaanxi and other provinces have the habit of harvesting.
Among them, the Weinan region of Shaanxi has the largest output
.
The supply of this species mainly depends on the supply of wild resources.
The supply of domestic species is currently in the early stage of development, and there are certain yields in a few areas
.
According to the statistics of the big data platform of the pharmaceutical industry in Tiandi Yuntu, the output of Xiebai in 2020 will be about 459 tons, and the output of Xiebai in 2021 will be about 436 tons
.
4.
The medicinal amount is small, Xiebai enters the lung, heart, stomach, and large intestine meridians, and has the functions of warming the middle and strengthening the stomach, clearing the yang and dissipating the knot, regulating the qi and widening the chest, eliminating food and guiding stagnation.
, Unable to eat, abdominal fullness and pain, diarrhea or dysentery, poor diarrhea, cough embolism
.
According to the statistics of the big data platform of the pharmaceutical industry in Tiandi Yuntu, the consumption of Xiebai will be around 434 tons in 2020, and about 445 tons in 2021
.
V.
Analysis of Main Demand Products and Enterprises In terms of demand for Chinese patent medicines, by screening 7,702 Chinese patent medicine varieties monitored by the platform, there are currently 17 Chinese patent medicines containing Xiebai, and the top Chinese patent medicines in demand are Xinnaoning Capsule, Blood Zhitong Capsules, Tongxiening Granules, etc.

.
The enterprises with the highest demand for Xiebai are Guizhou Jingcheng Pharmaceutical Co.
, Ltd.
, Jilin Province Dongfang Pharmaceutical Co.
, Ltd.
, and Chongqing Huasen Pharmaceutical Co.
, Ltd.
,
etc.
6.
Anticipation of the market outlook 1.
Wild resources are the main source, and labor costs continue to increase.
Although some areas have begun to develop family crops, the benefits are limited and the enthusiasm for planting is general
.
The supply of this variety to the market is still mainly wild.
At present, most of the harvesters are the elderly, the weak, women and children.
The harvesting capacity is limited and the output is difficult to guarantee
.
2.
The price is medium and the processing is cumbersome.
Now the price of 30 yuan in the origin has increased compared to the previous period, but it is still not considered a high price, it can only be regarded as a medium price, and farmers are generally motivated to harvest
.
Moreover, the processing of this variety is quite cumbersome, and the income of processing households is also limited
.
To sum up, as of now, the new output of Xiebai is limited, and the labor cost of harvesting and processing has increased, so the market price may rise in the future
.
However, the variety is widely distributed, and if the price rises too fast, it will stimulate the harvest and stimulate the development of domestic varieties
.
The medicinal demand of Xiebai is very limited, the contradiction between supply and demand is not prominent, and it is unlikely that it will rise sharply
.